SLC2A1 and invasive ductal breast carcinoma: Another IHC study by Sun et al. reported that GLUT1 was significantly overexpressed in the tissue of invasive ductal breast carcinoma (IDBC) with type 2 diabetes mellitus (T2DM) compared to those without T2DM, suggesting enhanced glucose uptake and metabolic reprogramming in IDC [97].